Skip to content

A Clinical Trail: Effect of Active release technique & Cyraix technique on pain, grip Strength and functional performance in individuals with Lateral Epicondylitis

Effect Of Active Release Technique And Cyriax Technique On Pain, Grip Strength, and Functional Performance In Individuals With Lateral Epicondylitis: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053660
Enrollment
60
Registered
2023-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M708- Other soft tissue disorders related to use, overuse and pressure

Interventions

Intervention1: Cyraix Technique: Cyriax and Cyriax claimed substantial success in treating tennis elbow using deep transverse friction (DTF) in combination with Millâ??s manipulation, which is perform

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pain- >3 months 2. The patient diagnosed with lateral epicondylitis 3. Those who intend to take part in the study

Exclusion criteria

Exclusion criteria: 1. History of trauma to the upper limb and cervical region 2. Any surgery the of upper limb and cervical region 3. Local infections 4. Local malignancy 6. Cervical radiculopathy 7. Recent steroid infiltration 8. Tennis elbow secondary to cervical radiculopathy.

Design outcomes

Primary

MeasureTime frame
1. Visual Analogue Scale (VAS)Timepoint: Outcome will be assessed at baseline and after 4 weeks.

Secondary

MeasureTime frame
1. Hand grip strength dynamometer 2. Patient-rated tennis elbow evaluation Timepoint: Outcome will be assessed at baseline and after 4 weeks.

Countries

India

Contacts

Public ContactDr Subrat Samal

Ravi Nair Physiotherapy College

research4subrat@gmail.com8007685011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026